Xbrane Biopharma

Hem
Sverige
Stockholm
Xbrane Biopharma

Vägbeskrivning Webbplats Kontakta affären

Xbrane Biopharma AB is a leading science based biosimilar developer of cost effective medicines with high unmet medical need.

Xbrane base its development on a patented high yield production platform and world-leading expertise. Xbrane has a portfolio targeting originator products with combined annual sales of €11billion. The leading product, Xlucane (ranibizumab biosimilar), is currently in Phase III with target to launch 2022. Xbrane’s headquarter is located in Solna, just outside of Stockholm. Xbrane is listed on Nasdaq Stockholm with the ticker XBRANE.

Adress

Banvaktsvägen 22
Stockholm
17148

Webbplats

http://www.xbrane.com/

Aviseringar

Bli först med att veta: vi skickar ett mejl när Xbrane Biopharma publicerar nyheter och kampanjer. Din e-postadress används inte till något annat, och du kan avsluta prenumerationen när som helst.